Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 9, 2017 - Issue
Submit an article Journal homepage
95
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Cost-consequence analysis of sitagliptin versus sulfonylureas as add-on therapy for the treatment of diabetic patients in Italy

Valentina Lorenzoni1 Institute of Management, Scuola Superiore Sant’Anna, Pisa, Italy
,
Fabio Baccetti2 SD Diabetology, ASL Toscana Nordovest, Massa Carrara, Italy
,
Stefano Genovese3 Cardiovascular and Metabolic Department, IRCCS Multimedica Sesto San Giovanni, Milan, Italy
,
Enrico Torre4 SSD Endocrinologia, Diabetologia e Malattie metaboliche, ASL 3 Genovese, Genoa, Italy
&
Giuseppe Turchetti1 Institute of Management, Scuola Superiore Sant’Anna, Pisa, ItalyCorrespondence[email protected]
Pages 699-710 | Published online: 20 Nov 2017

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Zhen Ruan, Huimin Zou, Qing Lei, Carolina Oi Lam Ung, Honghao Shi & Hao Hu. (2022) Pharmacoeconomic evaluation of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus: a systematic literature review. Expert Review of Pharmacoeconomics & Outcomes Research 22:4, pages 555-574.
Read now
Enrico Torre, Giacomo M Bruno, Sergio Di Matteo, Chiara Martinotti, Maria Chiara Valentino, Luigi C Bottaro & Giorgio L Colombo. (2020) Economic Evaluation of Dulaglutide vs Traditional Therapies: Implications of the Outcomes of the Rewind Study. ClinicoEconomics and Outcomes Research 12, pages 177-189.
Read now

Articles from other publishers (4)

Katy Sánchez-Pozos, María de los Ángeles Granados-Silvestre & María Guadalupe Ortíz-López. 2021. Drug Metabolism. Drug Metabolism.
AshokK Das, Pramod Gandhi, Banshi Saboo, Sanjay Reddy, Rajeev Chawla, AbdulHamid Zargar, Rajiv Kovil, Manoj Chawla, SK Sharma, Sunil Gupta, BM Makkar, Vinod Mittal, Soumik Goswami, SR Arvind, Shalini Jaggi, Sarita Bajaj & Sambit Das. (2021) Optimizing the treatment of newly diagnosed type 2 diabetes mellitus with combination of dipeptidyl peptidase-4 inhibitors and metformin: An expert opinion. Journal of Family Medicine and Primary Care 10:12, pages 4398.
Crossref
Yan Zhi Tan, McVin Hua Heng Cheen, Su‐Yen Goh, Yong Mong Bee, Paik Shia Lim, Giat Yeng Khee & Julian Thumboo. (2019) Trends in medication utilization, glycemic control and outcomes among type 2 diabetes patients in a tertiary referral center in Singapore from 2007 to 2017. Journal of Diabetes 11:7, pages 573-581.
Crossref
. (2017) Sitagliptin add-on therapy cost saving for T2DM in Italy. PharmacoEconomics & Outcomes News 792:1, pages 28-28.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.